adenine - CISMeF

Preferred Label : adenine;

MeSH definition : A purine base and a fundamental unit of ADENINE NUCLEOTIDES.;

MeSH synonym : 4, vitamin b; vitamin b 4; b 4, vitamin;

MeSH CAS label : 1H-Purin-6-amine;

MeSH Related Number : 73-24-5 (Adenine);

Registry Number MeSH : 73-24-5;

MeSH annotation : /biosyn/physiol permitted;

Wikipedia link : https://en.wikipedia.org/wiki/Adenine;

Codes EINECS : 200-796-1;

Is substance : O;

medicament (CISMeF) : O;

UNII : JAC85A2161;

InChIKey : GFFGJBXGBJISGV-UHFFFAOYSA-N;

Details

Origin ID

D000225;

UMLS CUI

C0001407;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- A Mouse [NCIt concept]
- Abnormal [ICNP judgement]
- Acre [NCIt concept]
- Adenine [ICHI extension code]
- Ampere [NCIt concept]
- Ampère [UCUM unit]
- Angstrom [NCIt concept]
- Anterior [FMA entity]
- Anterior [ICNP localization]
- Atypical Neurofibromatous Neoplasm of Uncertain Biologic Potential [NCIt concept]
- Axial [FMA entity]
- Blood Group A [NCIt concept]
- Child-Pugh Class A [NCIt concept]
- DIAPH3 wt Allele [NCIt concept]
- Double Immunodiffusion [NCIt concept]
- Due [NCIt concept]
- Due To [NCIt concept]
- Due to (attribute) [SNOMED CT concept]
- MATCH Arm EAY131-A [NCIt concept]
- PAX6 wt Allele [NCIt concept]
- Ventral [FMA entity]
- Year [NCIt concept]
- abnormal [SNOMED Notion]
- adenine [Blood Transfusion thesaurus concept]
- anterior [SNOMED Notion]
- axial [SNOMED Notion]
- due to [SNOMED Notion]
- unnatural [SNOMED Notion]
CISMeF manual mappings
- adenine [Substance BNPC]
Currated CISMeF NLP mapping
- Adenine [ICD-11 Extension code]
- Adenine [NCIt concept]
- Adenine [FMA entity]
- Adenine [LOINC component]
- Adenine (substance) [SNOMED CT concept]
- adenine [SNOMED Notion]
Record concept(s)
- adenine [MeSH concept]
Related MeSH Supplementary Concept(s)
- ((5-(adenin-9-yl)-2-furyl)methoxy)methyl phosphonic acid [MeSH Supplementary Concept]
- (1'S,2'S)-9-((2'-hydroxymethyl-1'-(methyl)cycloprop-1'-yl)methyl)adenine [MeSH Supplementary Concept]
- (11alpha,13-dihydro-7alpha-hydroxyfrullanolide-13-yl)-adenine [MeSH Supplementary Concept]
- (2R,3S)-3-(4-Amino-1H-imidazo(4,5-c)pyridin-1-yl)-2-nonanol [MeSH Supplementary Concept]
- (4-(5-furan-2-yl-3-methyl-1H-pyrazol-4-yl)-butyl)methyl-(7H-purin-6-yl)amine [MeSH Supplementary Concept]
- (9-methyl-adenine)(2)-(1-methyl-thymine)(2) [MeSH Supplementary Concept]
- (N(6)-adenyl)styrene oxide [MeSH Supplementary Concept]
- (P(1)-thymidine-3'-azido-2',3'-dideoxyriboside-5')-P(2)-(9-2-(phosphonomethoxypropyl)adenine) [MeSH Supplementary Concept]
- (Pt(MeNH(2))(2)(ChmT-N3)(ChmA-N1))NO(3) [MeSH Supplementary Concept]
- 1,3-dideaza-9-(2-hydroxy-3-nonyl)adenine [MeSH Supplementary Concept]
- 1,3-dideazaadenine [MeSH Supplementary Concept]
- 1,N(6)-ethanoadenine [MeSH Supplementary Concept]
- 1,N(6)-ethenoadenine [MeSH Supplementary Concept]
- 1,N6-alpha-hydroxypropanoadenine [MeSH Supplementary Concept]
- 1,N6-propanoadenine [MeSH Supplementary Concept]
- 1-(2-(6-amino-8-(3-fluorophenyl)-9-methyl-9H-2-purinyl)-1-ethynyl)-1-cyclopentanol [MeSH Supplementary Concept]
- 1-(2-carboxyethyl)adenine [MeSH Supplementary Concept]
- 1-(3'-amino-3'-carboxypropyl)adenine [MeSH Supplementary Concept]
- 1-(4-(2-(6-amino-8-((6-bromo-1,3-benzodioxol-5-yl)sulfanyl)-9H-purin-9-yl)ethyl)piperidin-1-yl)-2-hydroxypropan-1-one [MeSH Supplementary Concept]
- 1-(6-(3-chlorophenylamino)-9-isopropyl-9H-purin-2-yl)-3-methylpent-1-yn-3-ol [MeSH Supplementary Concept]
- 1-(6-(4-chlorobenzylamino)-9-isopropyl-9H-purin-2-yl)-3-methylpent-1-yn-3-ol [MeSH Supplementary Concept]
- 1-(9-adenyl)cyclopentan-3-ol [MeSH Supplementary Concept]
- 1-(hydroxymethyl)-4-(6-amino-9-purinyl)bicyclo(3.1.0)hexane [MeSH Supplementary Concept]
- 1-methyladenine [MeSH Supplementary Concept]
- 1V209 [MeSH Supplementary Concept]
- 2,2-dimethylpropionic acid 3-(2-chloro-6-methylaminopurin-9-yl)-2-(2,2-dimethylpropionyloxymethyl)propyl ester [MeSH Supplementary Concept]
- 2,6,8-triaminopurine [MeSH Supplementary Concept]
- 2,8-dihydroxyadenine [MeSH Supplementary Concept]
- 2,9-dimethyladenine [MeSH Supplementary Concept]
- 2-(2-(6-methylaminopurin-9-yl)ethyl)propane-1,3-bisoxy(diammonium phosphate) [MeSH Supplementary Concept]
- 2-(3,5-dimethylpyrazol-1-yl)adenine [MeSH Supplementary Concept]
- 2-(4-n-butylanilino)adenine [MeSH Supplementary Concept]
- 2-(9H-purin-6-ylamino)-4-(methylamino)butanoic acid [MeSH Supplementary Concept]
- 2-(N-iodoacetylaminoethyl)thioadenine [MeSH Supplementary Concept]
- 2-amino-6-chloro-9-(4-iodo-3,5-dimethylpyridin-2-ylmethyl)purine [MeSH Supplementary Concept]
- 2-amino-6-hydroxy-8-mercaptopurine [MeSH Supplementary Concept]
- 2-amino-7-deazaadenine [MeSH Supplementary Concept]
- 2-amino-N(6)-hydroxyadenine [MeSH Supplementary Concept]
- 2-amino-N(6)-methoxyadenine [MeSH Supplementary Concept]
- 2-amino-N(6)-methyl-N(6)-hydroxyadenine [MeSH Supplementary Concept]
- 2-aminooxetanocin A [MeSH Supplementary Concept]
- 2-azaadenine [MeSH Supplementary Concept]
- 2-butylamino-8-hydroxy-9-(6-methylpyridine-3-ylmethyl)adenine [MeSH Supplementary Concept]
- 2-chloro-6-(3-methoxyphenyl)aminopurine [MeSH Supplementary Concept]
- 2-chloro-N-(2-(5-(dimethylamino)naphthalene-1-sulfonamido)ethyl)-4-(2-(1-hydroxy-3-methylbutan-2-ylamino)-9-isopropyl-9H-purin-6-ylamino)benzamide [MeSH Supplementary Concept]
- 2-chloroadenine [MeSH Supplementary Concept]
- 2-fluoro-8-((2-chloro-3,4,5,-trimethoxyphenyl)methyl)-9-pentyladenine [MeSH Supplementary Concept]
- 2-fluoroadenine [MeSH Supplementary Concept]
- 2-methyladenine [MeSH Supplementary Concept]
- 2-methylthio-N(6)-(N-threonylcarbonyl)adenine [MeSH Supplementary Concept]
- 2-n-butyl-9-methyl-8-(1,2,3)triazol-2-yl-9H-purin-6-ylamine [MeSH Supplementary Concept]
- 2-phenylethoxy-9-methyladenine [MeSH Supplementary Concept]
- 2-trifluoromethyl-9-(2-fluorophenylmethyl)-N-methyladenine [MeSH Supplementary Concept]
- 3-(2-hydroxyethyl)adenine [MeSH Supplementary Concept]
- 3-(6-amino-9H-purin-9-yl)-cyclopentanol [MeSH Supplementary Concept]
- 3-(adenin-9-yl)propionhistamide [MeSH Supplementary Concept]
- 3-(benzyloxycarbonylleucylamino)-N-(3-(6-amino-9H-purin-9-yl)propyl)-2-oxopentanamide [MeSH Supplementary Concept]
- 3-adenin-9-yl-2-hydroxypropanoic acid [MeSH Supplementary Concept]
- 3-adenin-9-yl-2-hydroxypropanoic acid isobutyl ester [MeSH Supplementary Concept]
- 3-benzyladenine [MeSH Supplementary Concept]
- 3-deaza-3-methyladenine [MeSH Supplementary Concept]
- 3-deaza-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine [MeSH Supplementary Concept]
- 3-deazaadenine [MeSH Supplementary Concept]
- 3-ethyladenine [MeSH Supplementary Concept]
- 3-methyladenine [MeSH Supplementary Concept]
- 3-ribofuranosyl-9-(2'-deoxyribofuranosyl)-11-methyl-3H-pyrimido(1'',6''-1',2')imidazo(4',5'-4,5)imidazo(2,1-i)purin-8(9H)-one [MeSH Supplementary Concept]
- 4'-deaza-1'-aza-2'-deoxy-1'-(9-methylene)-immucillin A [MeSH Supplementary Concept]
- 4-(chlorophenyl)-(2-(3,5-dimethylpyrazol-1-yl)-9-methyl-9H-purin-6-yl)amine [MeSH Supplementary Concept]
- 4-amino-5-bromopyrrolo(2,3-d)pyrimidine [MeSH Supplementary Concept]
- 4-aminopyrazolo(3,4-d)pyrimidine [MeSH Supplementary Concept]
- 5'-methylthio-immucillin A [MeSH Supplementary Concept]
- 6'-fluoroaristeromycin [MeSH Supplementary Concept]
- 6-(2-hydroxy-2-methylbenzylamino)purine [MeSH Supplementary Concept]
- 6-N-hydroxylaminopurine [MeSH Supplementary Concept]
- 6-amino-9-(((-3-iodo-2-propenyl)oxy)methyl)purine [MeSH Supplementary Concept]
- 6-chloro-9-(4-methoxy-3,5-dimethylpyridin-2-ylmethyl)-9H-purin-2-ylamine [MeSH Supplementary Concept]
- 6-chloro-9-(5-methoxy-4,6-dimethylpyridin-3-ylmethyl)-9H-purin-2-ylamine [MeSH Supplementary Concept]
- 6-fluoroaminopurine [MeSH Supplementary Concept]
- 6-methyladenine [MeSH Supplementary Concept]
- 6-methyladenine [MeSH Supplementary Concept]
- 6-propyladenine [MeSH Supplementary Concept]
- 6N-acetyl-8-aza-7-deazaadenine [MeSH Supplementary Concept]
- 7,8-dimethylisoalloxazine-10-acetic acid-adenin-9-ylethylamine complex [MeSH Supplementary Concept]
- 7-((2-hydroxyethoxy)methyl)adenine [MeSH Supplementary Concept]
- 7-(3-(4-(3-chlorophenyl)piperazin-1-yl)propyl)adenine [MeSH Supplementary Concept]
- 7-(benzo(a)pyren-6-yl)adenine [MeSH Supplementary Concept]
- 7-(hydroxymethyl)-1,N(6)-ethenoadenine [MeSH Supplementary Concept]
- 7-deaza-9-(2-hydroxy-3-nonyl)adenine [MeSH Supplementary Concept]
- 7-deazaadenine [MeSH Supplementary Concept]
- 7-iodo-7-deazaadenine [MeSH Supplementary Concept]
- 7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine [MeSH Supplementary Concept]
- 7-methyl-8-azaadenine [MeSH Supplementary Concept]
- 7-methyladenine [MeSH Supplementary Concept]
- 8-((3,5-dichlorophenyl)thio)-9-(3-(isopropylamino)propyl)-9H-purin-6-amine [MeSH Supplementary Concept]
- 8-(2-furyl)adenine [MeSH Supplementary Concept]
- 8-(2-iodo-5-methoxyphenylsulfanyl)-9-(3-isopropylaminiopropyl)-9H-purin-6-ylamine [MeSH Supplementary Concept]
- 8-(3-(3-fluorosulfonylbenzamido)benzylthio)adenine [MeSH Supplementary Concept]
- 8-(pyrene-1-yl)-ethynyladenine [MeSH Supplementary Concept]
- 8-aza-7-deazaadenine [MeSH Supplementary Concept]
- 8-aza-9-furfuryladenine [MeSH Supplementary Concept]
- 8-azaadenine [MeSH Supplementary Concept]
- 8-azidoadenine [MeSH Supplementary Concept]
- 8-bromo-2-(1-octyn-1-yl)-N9-propargyladenine [MeSH Supplementary Concept]
- 8-bromo-9-ethyladenine [MeSH Supplementary Concept]
- 8-bromo-9-methyladenine [MeSH Supplementary Concept]
- 8-bromoadenine [MeSH Supplementary Concept]
- 8-chloroadenine [MeSH Supplementary Concept]
- 8-dimethylamino-1-methyladenine [MeSH Supplementary Concept]
- 8-ethoxy- 9-ethyladenine [MeSH Supplementary Concept]
- 8-furyl-9-ethyladenine [MeSH Supplementary Concept]
- 8-hydroxyadenine [MeSH Supplementary Concept]
- 8-methyladenine [MeSH Supplementary Concept]
- 8-oxo-7,8-dihydroadenine [MeSH Supplementary Concept]
- 8-tert-butyladenine [MeSH Supplementary Concept]
- 9((2-methyl-4-methylene-5-oxotetrahydrofuran-2-yl)methyl)adenine [MeSH Supplementary Concept]
- 9-((1-(4-acetyl-phenyloxy)-ethyl)-2-)adenine [MeSH Supplementary Concept]
- 9-((2,5-dihydro-5-phosphonomethoxy)-2-furanyl)adenine [MeSH Supplementary Concept]
- 9-((2-phenylalanylamidoethoxy)methyl)adenine [MeSH Supplementary Concept]
- 9-((Z)-13-docosenyl)adenine [MeSH Supplementary Concept]
- 9-(1,3-anhydro-beta-D-psicofuranosyl)adenine [MeSH Supplementary Concept]
- 9-(1-hydroxy-2-octyl)adenine [MeSH Supplementary Concept]
- 9-(2',3'-dideoxy-2',3'-didehydro-2'-fluoro-6'-hydroxymethylcyclopent-2-enyl)adenine [MeSH Supplementary Concept]
- 9-(2'-deoxyribosyl)-6-(3,5-diformyl-4-methyl-1,4-dihydro-1-pyridyl)purine [MeSH Supplementary Concept]
- 9-(2,3-dihydroxypropyl)adenine [MeSH Supplementary Concept]
- 9-(2-((bis(pivaloyloxymethoxy)phosphinoyl)methoxy)propyl)adenine [MeSH Supplementary Concept]
- 9-(2-(2,2-dimethylpropylamino)ethyl)-8-(2-iodo-5-methoxyphenylsulfanyl)-9H-purin-6-ylamine [MeSH Supplementary Concept]
- 9-(2-(4-isopropylphenoxy)ethyl)adenine [MeSH Supplementary Concept]
- 9-(2-(boranophosphonomethoxy)ethyl)adenine [MeSH Supplementary Concept]
- 9-(2-(boranophosphonomethoxy)propyl)adenine [MeSH Supplementary Concept]
- 9-(2-(phosphonomethoxy)-3-hydroxypropyl)-8-azaadenine [MeSH Supplementary Concept]
- 9-(2-(phosphonomethoxy)ethyl)-N(6)-(2-dimethylaminoethyl)-2,6-diaminopurine [MeSH Supplementary Concept]
- 9-(2-(phosphonomethoxy)ethyl)-N(6)-allyl-2,6-diaminopurine [MeSH Supplementary Concept]
- 9-(2-(phosphonomethoxy)ethyl)-N(6)-dimethyl-2,6-diaminopurine [MeSH Supplementary Concept]
- 9-(2-(phosphonomethoxy)ethyl)adenine diphosphate [MeSH Supplementary Concept]
- 9-(2-bromoacetamidobenzyl)adenine [MeSH Supplementary Concept]
- 9-(2-bromoethyl)adenine [MeSH Supplementary Concept]
- 9-(2-chloro-6-fluorobenzyl)-6-dimethylaminopurine [MeSH Supplementary Concept]
- 9-(2-chloro-6-fluorobenzyl)-6-methylaminopurine [MeSH Supplementary Concept]
- 9-(2-chlorobenzyl)adenine [MeSH Supplementary Concept]
- 9-(2-diallylaminoethyl)adenine [MeSH Supplementary Concept]
- 9-(2-diallylaminoethyl)adenine hydrochloride [MeSH Supplementary Concept]
- 9-(2-hydroxy-3-nonyl)-1-deazaadenine [MeSH Supplementary Concept]
- 9-(2-hydroxy-3-nonyl)adenine [MeSH Supplementary Concept]
- 9-(2-hydroxyethylidene)-cyclopropyl adenine [MeSH Supplementary Concept]
- 9-(2-hydroxypropyl)adenine [MeSH Supplementary Concept]
- 9-(2-methoxybenzyl)adenine [MeSH Supplementary Concept]
- 9-(2-methylbenzyl)adenine [MeSH Supplementary Concept]
- 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine [MeSH Supplementary Concept]
- 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine [MeSH Supplementary Concept]
- 9-(2-thiophosphonomethoxy)propyl)adenine [MeSH Supplementary Concept]
- 9-(3'-formyl-2,'3'-dihydroxypropyl)adenine [MeSH Supplementary Concept]
- 9-(3,4-dihydroxybutyl)adenine [MeSH Supplementary Concept]
- 9-(3-(aden-9-yl)propyl)-2-dimethylaminopurin-6-one [MeSH Supplementary Concept]
- 9-(3-azido-2-hydroxypropyl)adenine [MeSH Supplementary Concept]
- 9-(3-bromo-2-(2,3-dibromo-4,5-dihydroxybenzyl)-4,5-dihydroxybenzyl)adenine [MeSH Supplementary Concept]
- 9-(3-deoxy-beta-D-glycero-pent-3-enofuranosyl)adenine [MeSH Supplementary Concept]
- 9-(3-fluoro-2-phosphonylmethoxypropyl)adenine [MeSH Supplementary Concept]
- 9-(3-hydroxy-2-phosphonomethoxypropyl)-2,6-diaminopurine [MeSH Supplementary Concept]
- 9-(3-oxoprop-1-enyl)adenine [MeSH Supplementary Concept]
- 9-(3-phenylalanylamidopropyl)adenine [MeSH Supplementary Concept]
- 9-(3-sec-butylaminopropyl)-8-(2-iodo-5-methoxyphenylsulfanyl)-9H-purin-6-ylamine [MeSH Supplementary Concept]
- 9-(4,5-bishydroxymethylcyclopent-2-en-1-yl)-9H-adenine [MeSH Supplementary Concept]
- 9-(4-(1,2-dihydroxyethyl)cyclopent-2-en-1-yl)-9H-adenine [MeSH Supplementary Concept]
- 9-(4-bromoacetamidobenzyl)adenine [MeSH Supplementary Concept]
- 9-(4-hydroxy-2-buten-1-yl)adenine [MeSH Supplementary Concept]
- 9-(S)-(3-hydroxy-2-(phosphonomethoxy)propyl)adenine [MeSH Supplementary Concept]
- 9-(bis(hydroxymethyl)thietan-1'-yl)adenine [MeSH Supplementary Concept]
- 9-(c-4,t-5-bis(hydroxymethyl)cyclopent-2-en-r-1-yl)-9H-adenine [MeSH Supplementary Concept]
- 9-(indole-3-propyl)-1-methyladeninium [MeSH Supplementary Concept]
- 9-(n-butyl)-8-((3,4,5-trimethoxyphenyl)methyl)adenine [MeSH Supplementary Concept]
- 9-(pent-4-ynyl)-8-(6-bromobenzo(1,3)dioxol-5-ylsulfanyl)adenine [MeSH Supplementary Concept]
- 9-(tetrahydro-2-furyl)-adenine [MeSH Supplementary Concept]
- 9-benzyl-2-butoxy-8-hydroxyadenine [MeSH Supplementary Concept]
- 9-benzyl-8-hydroxy-2-(2-hydroxyethylthio)adenine [MeSH Supplementary Concept]
- 9-benzyladenine [MeSH Supplementary Concept]
- 9-beta-D-erythrofuranosyladenine [MeSH Supplementary Concept]
- 9-cyclohexyl-2-n-propoxy-9H-adenine [MeSH Supplementary Concept]
- 9-cyclohexyladenine [MeSH Supplementary Concept]
- 9-ethyladenine [MeSH Supplementary Concept]
- 9-furfuryladenine [MeSH Supplementary Concept]
- 9-methyladenine [MeSH Supplementary Concept]
- 9-propargyladenine [MeSH Supplementary Concept]
- ADAAV solution [MeSH Supplementary Concept]
- ADSOL [MeSH Supplementary Concept]
- AL622 [MeSH Supplementary Concept]
- AP 23451 [MeSH Supplementary Concept]
- AP 24163 [MeSH Supplementary Concept]
- AS-3 preservative solution [MeSH Supplementary Concept]
- AS-3 solution [MeSH Supplementary Concept]
- ATPFU compound [MeSH Supplementary Concept]
- BG-Cy3-Cy5 [MeSH Supplementary Concept]
- CC-1065-(N(3)-adenine)-DNA [MeSH Supplementary Concept]
- CPDA solutions [MeSH Supplementary Concept]
- DS7423 [MeSH Supplementary Concept]
- DSR-29133 [MeSH Supplementary Concept]
- DSR-6434 [MeSH Supplementary Concept]
- GS-9131 [MeSH Supplementary Concept]
- GSK2245035 [MeSH Supplementary Concept]
- GSK2656157 [MeSH Supplementary Concept]
- H717 compound [MeSH Supplementary Concept]
- Henri-Mondor solution [MeSH Supplementary Concept]
- IC 87114 [MeSH Supplementary Concept]
- L 628914 [MeSH Supplementary Concept]
- MAP solution [MeSH Supplementary Concept]
- MDL 108522 [MeSH Supplementary Concept]
- MPI-0479605 [MeSH Supplementary Concept]
- N 0861 [MeSH Supplementary Concept]
- N(3)-(11,12,13,14-tetrahydro-11,12,13-trihydroxydibenzo(a,l)pyren-14-yl)adenine [MeSH Supplementary Concept]
- N(6),N(6)-dimethyladenine [MeSH Supplementary Concept]
- N(6)-((chrysen-5-yl)methyl)adenine [MeSH Supplementary Concept]
- N(6)-(1,3-dimethyl-2-butenyl)adenine [MeSH Supplementary Concept]
- N(6)-(2,2,6,6-tetramethyl-1-oxypiperidin-4-yl)adenine [MeSH Supplementary Concept]
- N(6)-(2-carboxyethyl)adenine [MeSH Supplementary Concept]
- N(6)-(3-hydroxy-3-methylbutyl)adenine [MeSH Supplementary Concept]
- N(6)-benzoyladenine-3-hydroxypyridinium-2-carboxylate [MeSH Supplementary Concept]
- N(6)-benzoyladenine-DL-tartaric acid [MeSH Supplementary Concept]
- N(6)-cyclopentyl-9-methyladenine [MeSH Supplementary Concept]
- N(6)-cyclopropyl-9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine [MeSH Supplementary Concept]
- N(6)-dimethyl-N(9)-ethyladenine [MeSH Supplementary Concept]
- N(6)-methoxyadenine [MeSH Supplementary Concept]
- N(6)-methyl-N(6)-(N-threonylcarbonyl)adenine [MeSH Supplementary Concept]
- N(7)-(11,12,13,14-tetrahydro-11,12,13-trihydroxydibenzo(a,l)pyren-14-yl)adenine [MeSH Supplementary Concept]
- N-(purin-6-ylcarbamoyl)threonine [MeSH Supplementary Concept]
- N-lauroyl-1-(3-chlorophenyl)-1,3-propanyl phosphonyl adefovir [MeSH Supplementary Concept]
- N2-(4-aminocyclohexyl)-9-cyclopentyl-N6-(6-(2-hydroxyphenyl)pyridin-3-ylmethyl)-9H-purine-2,6-diamine [MeSH Supplementary Concept]
- N3-(2-carbamoyl-2-hydroxyethyl)adenine [MeSH Supplementary Concept]
- N3-carboxymethyladenine [MeSH Supplementary Concept]
- N3-methyladenine [MeSH Supplementary Concept]
- N6-(2-hydroxy-3-buten-1-yl)adenine [MeSH Supplementary Concept]
- N6-benzoyladenine [MeSH Supplementary Concept]
- N8-(2'-O-methylribofuranosyl)-8-aza-7-deazaadenine monohydrate [MeSH Supplementary Concept]
- NAD kinase inhibitor NKI1 [MeSH Supplementary Concept]
- PAGGS-M solution [MeSH Supplementary Concept]
- PAGGS-sorbitol solution [MeSH Supplementary Concept]
- PCI-45227 [MeSH Supplementary Concept]
- PF 5168899 [MeSH Supplementary Concept]
- S-CR8 compound [MeSH Supplementary Concept]
- SM360320 [MeSH Supplementary Concept]
- ST3932 [MeSH Supplementary Concept]
- ST4206 [MeSH Supplementary Concept]
- SZU-101 [MeSH Supplementary Concept]
- TMX-202 [MeSH Supplementary Concept]
- TMX201 [MeSH Supplementary Concept]
- TX1-85-1 [MeSH Supplementary Concept]
- UNC2025 [MeSH Supplementary Concept]
- WRC 0571 [MeSH Supplementary Concept]
- adefovir [MeSH Supplementary Concept]
- adefovir dipivoxil [MeSH Supplementary Concept]
- adenallene [MeSH Supplementary Concept]
- adenine thiamine diphosphate [MeSH Supplementary Concept]
- adenine-(1'R,2'R,3'R)-cyclic butanetetraol carbonate [MeSH Supplementary Concept]
- adenine-N-oxide [MeSH Supplementary Concept]
- adenine-uracil dimers [MeSH Supplementary Concept]
- adeninediium hemioxalate chloride [MeSH Supplementary Concept]
- adeninium dinitrate [MeSH Supplementary Concept]
- adeninylethylcobalamin [MeSH Supplementary Concept]
- aftin-4 [MeSH Supplementary Concept]
- agelasimine A [MeSH Supplementary Concept]
- agelasimine B [MeSH Supplementary Concept]
- agelasine G [MeSH Supplementary Concept]
- agelasine H [MeSH Supplementary Concept]
- agelasine I [MeSH Supplementary Concept]
- alpha-(N6-adenyl)styrene oxide [MeSH Supplementary Concept]
- alpha-(N6-adenyl)styrene oxide-DNA adduct [MeSH Supplementary Concept]
- aminopurvalanol A [MeSH Supplementary Concept]
- amonafide [MeSH Supplementary Concept]
- aphrocallistin [MeSH Supplementary Concept]
- arprinocid [MeSH Supplementary Concept]
- arprinocid-N-oxide [MeSH Supplementary Concept]
- benzodeazaadenine [MeSH Supplementary Concept]
- bictegravir, emtricitabine, tenofovir alafenamide, drug combination [MeSH Supplementary Concept]
- bis(adeninato-N(9))-diphenyltin IV [MeSH Supplementary Concept]
- bis(hydroxymethyl)cyclopentenyl adenine [MeSH Supplementary Concept]
- bis(isopropyloxymethylcarbonyl) 9-(2-phosphonomethoxypropyl)adenine [MeSH Supplementary Concept]
- bis(isopropyloxymethylcarbonyl)-9-(2-phosphonomethoxyethyl)adenine [MeSH Supplementary Concept]
- bis(pivaloyloxymethyl)-9-(2-phosphonylmethoxyethyl)adenine [MeSH Supplementary Concept]
- bis-9-(2-phosphonylmethoxyethyl)adenine [MeSH Supplementary Concept]
- carbocyclic deoxyadenosine [MeSH Supplementary Concept]
- cobalt-9-methyladenine [MeSH Supplementary Concept]
- cyclic-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine [MeSH Supplementary Concept]
- cyclobut A [MeSH Supplementary Concept]
- cyclopentenyladenine [MeSH Supplementary Concept]
- diethyl 2,2'-(((((3-(adenin-9-yl)-1-methoxy-1-oxopropan-2-yl)oxy)methyl)phosphoryl)bis(azanediyl))bis(2-phenylpropanoate) [MeSH Supplementary Concept]
- diphenyl-9-(2-phosphonylmethoxyethyl)adenine [MeSH Supplementary Concept]
- discadenine [MeSH Supplementary Concept]
- dodecaglycerol-adenine [MeSH Supplementary Concept]
- emtricitabine tenofovir alafenamide [MeSH Supplementary Concept]
- eritadenine [MeSH Supplementary Concept]
- erythro-(3-nonyl-p-aminobenzyl-adenine) [MeSH Supplementary Concept]
- erythropifaden [MeSH Supplementary Concept]
- etaden [MeSH Supplementary Concept]
- ethyl 3-(adenin-9-yl)-2-((((2-ethoxy-2-oxo-1-phenylethyl)amino)(phenoxy)phosphoryl)methoxy)propanoate [MeSH Supplementary Concept]
- ethyl adenine-9-acetate [MeSH Supplementary Concept]
- fluorobutynol [MeSH Supplementary Concept]
- galidesivir [MeSH Supplementary Concept]
- ganoderpurine [MeSH Supplementary Concept]
- hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine [MeSH Supplementary Concept]
- ibrutinib [MeSH Supplementary Concept]
- lamivudine-adefovir combination [MeSH Supplementary Concept]
- longdaysin [MeSH Supplementary Concept]
- meradine [MeSH Supplementary Concept]
- methyl 4-(adenin-9-yl)-2-hydroxybutanoate [MeSH Supplementary Concept]
- methylthio-DADMe-immucillin-A [MeSH Supplementary Concept]
- octadecyloxyethyl 9-(3-hydroxy-2-(phosphonomethoxy)propyl)adenine [MeSH Supplementary Concept]
- oxetanocin [MeSH Supplementary Concept]
- peanut agglutinin-N(6)-benzylaminopurine complex [MeSH Supplementary Concept]
- poly(9-vinyladenine) [MeSH Supplementary Concept]
- pradefovir [MeSH Supplementary Concept]
- puquitinib [MeSH Supplementary Concept]
- purfalcamine [MeSH Supplementary Concept]
- purvalanol B [MeSH Supplementary Concept]
- sapanisertib [MeSH Supplementary Concept]
- sodium nitroprusside adenine complex [MeSH Supplementary Concept]
- synadenol [MeSH Supplementary Concept]
- tenofovir alafenamide [MeSH Supplementary Concept]
- tenofovir diphosphate [MeSH Supplementary Concept]
- trichloro(8-azaadeninium)zinc(II) [MeSH Supplementary Concept]
- trimethylene-N(6),N(6')-bisadenine [MeSH Supplementary Concept]
- vita-iodouroltriphosphadenine [MeSH Supplementary Concept]
Semantic type(s)
- Biologically Active Substance [UMLS semantic type]
- Nucleic Acid, Nucleoside, or Nucleotide [UMLS semantic type]
UMLS correspondences (same concept)
- Adenine [ICD-11 Extension code]
- Adenine [FMA entity]
- Adenine [NCIt concept]
- Adenine [LOINC component]
- Adenine (substance) [SNOMED CT concept]
- adenine [Substance BNPC]
- adenine [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients